Insulin Aspart Injection and Ramucirumab Intravenous
Determining the interaction of Insulin Aspart Injection and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Aspart Injection-Ranexa
- Insulin Aspart Injection-Ranibizumab
- Insulin Aspart Injection-Ranibizumab Intraocular
- Insulin Aspart Injection-Ranibizumab ophthalmic
- Insulin Aspart Injection-Ranitidine
- Insulin Aspart Injection-Ranitidine Capsule
- Ramucirumab Intravenous-Insulin Aspart Protamine and Insulin Aspart
- Ramucirumab Intravenous-Insulin aspart protamine and insulin aspart Subcutaneous
- Ramucirumab Intravenous-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Ramucirumab Intravenous-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Ramucirumab Intravenous-Insulin Aspart Protamine Injection
- Ramucirumab Intravenous-Insulin aspart, recombinant Subcutaneous